Company Prestige Biologics Co., Ltd.

A334970

KR7334970001

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Biopharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
3,990 ^KRW	-0.62%		-3.74%	-9.32%

2023	Prestige Biologics Co., Ltd. announced that it has received KRW 45.5 billion in funding from Octava Fund Limited	CI
2023	Prestige Biologics Co., Ltd. announced that it expects to receive KRW 45.5 billion in funding from Octava Fund Limited	CI

Prestige Biologics Co Ltd is a Korean-based company mainly engaged in the business of developing and manufacturing biopharmaceuticals. The Company mainly engages in the contract manufacturing service business that produces and supplies biopharmaceuticals; and contract development service business that provides development services including cell culture process and purification process.

KRW in Million	2023	Weight	Delta
Daily Medicine 100.0 %	3,461	100.0 %	-

KRW in Million	2023	Weight	Delta
South Korea 100.0 %	3,461	100.0 %	-

Managers	Title	Age	Since
Duk-Hoon Hyun CEO	Chief Executive Officer	-	-
Yeong-Su Im DFI	Director of Finance/CFO	61	30/09/19
U-Seok Go BRD	Director/Board Member	59	29/02/20
Tae-Won Ban BRD	Director/Board Member	50	31/12/18
Jae-Yeong Yang BRD	Director/Board Member	60	31/12/18
Cheong-Seok Seo AUD	Comptroller/Controller/Auditor	79	31/12/18

Members of the board	Title	Age	Since
Jae-Yeong Yang BRD	Director/Board Member	60	31/12/18
Tae-Won Ban BRD	Director/Board Member	50	31/12/18
U-Seok Go BRD	Director/Board Member	59	29/02/20
Yeong-Jun Kim BRD	Director/Board Member	62	28/02/19
Dae-Hyeon Shin BRD	Director/Board Member	41	13/01/19
Hyeon-Cheol Dong BRD	Director/Board Member	63	31/07/19
Yeong-Wuk An BRD	Director/Board Member	69	29/02/00

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	61,501,469	27,455,992 ( 44.64 %)	0	44.64 %

Name	Equities	%	Valuation
PRESTIGE BIOPHARMA LIMITED 24.73 %	15,206,560	24.73 %	49 M ₩
So-yun Park 12.70 %	7,807,821	12.70 %	25 M ₩
Jin-woo Kim 12.54 %	7,711,601	12.54 %	25 M ₩
Octava Fund Ltd. 5.282 %	3,248,584	5.282 %	10 M ₩
Kamur Partners Co., Ltd. 4.493 %	2,763,014	4.493 %	9 M ₩
Joon-young Kwak 0.4406 %	270,970	0.4406 %	869 930 ₩
Hyeon-Cheol Dong 0.1301 %	80,000	0.1301 %	256 834 ₩
Jae-Yeong Yang 0.0732 %	45,000	0.0732 %	144 469 ₩
Duk-Hoon Hyun 0.0455 %	27,962	0.0455 %	89 770 ₩
Yeong-Su Im 0.0300 %	18,449	0.0300 %	59 229 ₩

Prestige Biologics Co., Ltd.

197, Osongsaengmyeong 1-ro Osong-eup

28161, Cheongju-si

http://www.pbpharma.co.kr

address Prestige Biologics Co., Ltd.(A334970)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
PRESTIGE BIOLOGICS CO., LTD.	-9.32%	178M
CSL LIMITED	+2.99%	95.18B
SAMSUNG BIOLOGICS CO.,LTD.	-4.34%	37.55B
BIOGEN INC.	-10.41%	33.75B
UCB	+75.79%	28.2B
BIOMARIN PHARMACEUTICAL INC.	-14.61%	15.63B
INCYTE CORPORATION	-3.46%	13.63B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.31%	11.5B
ALTEOGEN INC.	+184.77%	10.81B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54.13%	9.23B

Biopharmaceuticals